课题基金 / 基金详情

The prognosic value of the transcription of tumor growth-related genes in endoscopic biopsy specimens from patients with malignancies of digestive tracts

The prognosic value of the transcription of tumor growth-related genes in endoscopic biopsy specimens from patients with malignancies of digestive tracts
消化道恶性肿瘤内镜活检标本中肿瘤生长相关基因转录的预后价值
批准号:
08671460
负责人:
KATANO Mitsuo
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

KATANO Mitsuo的其他基金

相似基金

相关文献

中文摘要
翻译
胃癌患者术前内镜检查时获得肿瘤活检标本。从每个活检标本中提取总RNA,并使用逆转录酶-聚合酶链反应分析(RT-PCR)来分析肿瘤生长相关基因的转录。细胞周期相关因子包括细胞周期蛋白D 1和细胞周期蛋白E,侵袭相关因子包括尿激酶型纤溶酶原激活剂和72 kd IV型胶原酶,血管生成相关因子包括血管内皮生长因子和血小板源性生长因子A,免疫抑制相关因子包括转化生长因子B b和白细胞介素10。(1)PDGF-A和TGF-β mRNA的表达分别是早期胃癌和进展期胃癌术前淋巴结转移的指标。(2)PDGF-A和TGF-b是术前预后指标。(3)术前评估每种癌的恶性潜能可能会导致更合理的胃癌分类。
英文摘要
The tumor biopsy specimens were obtained during preoperative endoscopy of patients with gastric carcinoma. The total RNA from each biopsy specimen was isolated and a reverse trascriptase-polymerase chain reaction analysis (RT-PCR) was used to analyze the transcription of tumor growth-related genes. The factors examined included cyclin D1 and cyclin E as cell cycle-related factors, urokinase-type plasminogen activator and 72-kd type IV collagenase as invasion-related ones, vascular endothelial growth factor and platelet-derived growth factor-A as angiogenesis-related ones, and transforming growth factor b and interleukin-10 as immunosuppression-related ones.Results :(1) The incidence of PDGF-A and TGF-b mRNA expression was preoperative indicator of lymph node involvement in early and advanced gastric cartcinomas, respctively.(2) PDGF-A and TGF-b were preoperative prognostic indicators.(3) Preoperative evaluation of malignant potential of each carcinoma may lead to a more reasonable classification for gastric carcinomas.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Nakamura M: "A new prognostic strategy for gastric carcinoma:mRNA expression of tunsor growth-related factors in endoscopic biopsy specimens" Ann Surg. 226. 35-42 (1997)
Nakamura M:“胃癌的新预后策略:内窥镜活检标本中肿瘤生长相关因子的 mRNA 表达”Ann Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Anan K,Morisaki T,Katano M,Ikubo A,Tsukahara Y,Uchiyama A,Kuroki S,Tanaka M,Torisu M: "Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate sample of breast carcinoma : fine needle aspirates Vs.
Anan K、Morisaki T、Katano M、Ikubo A、Tsukahara Y、Uchiyama A、Kuroki S、Tanaka M、Torisu M:“通过乳腺癌匀浆样本中血管内皮生长因子 mRNA 表达对肿瘤血管生成进行术前评估:细针抽吸
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katano M: "Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma" Ann Surg. (in press).
Katano M:“血小板衍生生长因子-A (PDGF-A) 在胃癌中的预后价值”Ann Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
片野光男: "癌性腹膜炎治療を通して学ぶ臨床腫瘍免疫学" 癌と化学療法社, 230 (1997)
Mitsuo Katano:“通过治疗癌性腹膜炎学到的临床肿瘤免疫学”癌症和化疗出版,230(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 28 条
    Development of cancer therapy targeting Hedgehog signaling network
    • 批准号:
      24390303
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2012
    • 负责人:
      KATANO Mitsuo
    • 依托单位:
    Estabishment of G0 cancer cell model for the development of therapeutic strategy to target seceding from and re-entry into cell cycle in cancer cell
    • 批准号:
      23659616
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      KATANO Mitsuo
    • 依托单位:
    Functional analysis of Gli1 molecule for developing a new inclusive therapy against many tumor species
    • 批准号:
      21390363
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2009
    • 负责人:
      KATANO Mitsuo
    • 依托单位:
    Comprehensive analysis of morphogenesis signaling pathways for the development of organ-specific anticancer therapy
    • 批准号:
      19390337
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2007
    • 负责人:
      KATANO Mitsuo
    • 依托单位:
    海外基金